Pitt JI. Toxigenic fungi and mycotoxins.  Br Med Bull.2000;56:184-192.
Hendry KM, Cole EC. A review of mycotoxins in indoor air.  J Toxicol Environ Health.1993;38:183-198.
Wogan GN, Newberne PM. Dose-response characteristics of aflatoxin B1carcinogenesis
in the rat.  Cancer Res.1967;27:2370-2376.
Van Rensburg SJ. Role of epidemiology in the elucidation of mycotoxin health risks. In: Rodericks JV, Hesseltine CW, Mehlman MA, eds. Mycotoxicosis in Human and Animal Health. Park Forest South, Ill: Pathtox;
1977:699-711.
Campbell TC. Mycotoxins. In: Wynder EE, ed. Environmental Aspects of Cancer:
The Role of Macro and Micro Components of Foods. Westport, Conn: Food
and Nutrition Press; 1983:187-197.
Wang JS, Shen X, He X.
 et al.  Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.  J Natl Cancer Inst.1999;91:347-354.
Jackson PE, Groopman JD. Aflatoxin and liver cancer.  Baillieres Best Pract Res Clin Gastroenterol.1999;13:545-555.
Krishuamachari KAVR, Nagarajan V, Bhat RV, Tilak TBG. Hepatitis due to aflatoxicosis: an outbreak in Western India.  Lancet.1975;1:1061-1062.
Barger G. Ergot and Ergotism. London, England: Garney & Jackson; 1931.
Lewis WH. Medical Botany. New York, NY: John Wiley & Sons; 1977:416-418.
Smith JE, Solomons G, Lewis C, Anderson JG. Role of mycotoxins in human and animal nutrition and health.  Nat Toxins.1995;3:187-192.
Caballero-Granado FJ, Viciana P, Cordero E.
 et al.  Ergotism related to concurrent administration of ergotamine tartrate
and ritonavir in an AIDS patient.  Antimicrob Agents Chemother.1997;41:1207.
Rosenthal E, Sala F, Chichmanian RM.
 et al.  Ergotism related to concurrent administration of ergotamine tartrate
and indinavir.  JAMA.1999;281:987.
Marasas WFO. Discovery and occurrence of the fumonisins: a historical perspective.  Environ Health Perspect.2001;109 Suppl 2:239-243.
Not Available.  Fumonisin B1 . Geneva, Switzerland: World Health Organization; 2000. Environmental
Health Criteria, No. 219.
Ross PF, Rice LG, Reagor JC.
 et al.  Fumonisin B1 concentrations in feeds from 45 confirmed equine
leukoencephalomalacia cases.  J Vet Diagn Invest.1991;3:238-241.
Ross PF, Nelson PE, Richard JL.
 et al.  Production of fumonisins by Fusarium moniliforme and Fusarium proliferatum isolates associated
with equine leukoencephalomalacia and a pulmonary edema symdrome in swine.  Appl Environ Microbiol.1990;56:3225-3226.
Bane DP, Neumann EJ, Hall WF.
 et al.  Relationship between fumonisin contamination of feed and mystery swine
disease: a case-control study.  Mycopathologia.1992;117:121-124.
Merrill Jr AH, Sullards MC, Wang E, Voss KA, Riley RT. Sphingolipid metabolism: roles in signal transduction and disruption
by fumonisins.  Environ Health Perspect.2001;109 Suppl 2:283-289.
Hendricks K. Fumonisins and neural tube defects in south Texas.  Epidemiology.1999;10:198-200.
Missmer S, Hendricks KA, Suarez L, Larsen RD, Rothman KJ. Fumonisins and neural tube defects.  Epidemiology.2000;11:183-184.
Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border, 1993-1995.  Am J Epidemiol.1999;149:1119-1127.
Suarez L, Hendricks KA, Cooper SP.
 et al.  Neural tube defects among Mexican Americans living on the US-Mexico
border.  Am J Epidemiol.2000;152:1017-1023.
Stevens VL, Tang J. Fumonisin B1-induced sphyngolipid depletion inhibits vitamin
uptake via the glycosylphosphatidylinositol-anchored folate receptor.  J Biol Chem.1997;272:18020-18025.
Joffe AZ. Foodborne diseases. In: Rechcigle M, ed. Handbook of Foodborne Disease
of Biological Origin. Boca Raton, Fla: CRC Press; 1983:351-495.
Forgacs J. Stachybotryotoxicosis. In: Kadis S, Ciegler A, Ajl S, eds. Microbial Toxins,
Vol. III. New York, NY: Academic Press; 1972.
Drobotko VG. Stachybotryotoxicosis, a new disease of horses and humans.  Am Rev Soviet Med.1945;2:238-242.
Luo XY. Outbreaks of moldy cereal poisonings in China. In: Toxicology Forum and the Chinese Academy of
Preventive Medicine: Issues in Food Safety. Washington, DC: Toxicology
Forum; 1988:56-63.
Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. Outbreak of trichothecene mycotoxicosis associated with consumption
of mould-damaged wheat products in Kashmir Valley, India.  Lancet.1989;1:35-37.
Centers for Disease Control and Prevention.  Outbreaks of gastrointestinal illness of unknown etiology associated
with eating burritos—United States, October 1997—October 1998.  MMWR Morb Mortal Wkly Rep.1999;48:210-213.
Etzel RA, Montana E, Sorenson WG.
 et al.  Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi.  Arch Pediatr Adolesc Med.1998;152:757-762.
Not Available.  Update: pulmonary hemorrhage/hemosiderosis among infants—Cleveland,
Ohio, 1993-1996.  MMWR Morb Mortal Wkly Rep.2000;49:180-184.
Flappan SM, Portnoy J, Jones P, Barnes C. Infant pulmonary hemorrhage in a suburban home with water damage and
mold (Stachybotrys atra).  Environ Health Perspect.1999;107:927-930.
Elidemir O, Colasurdo GN, Rossmann SN, Fan LL. Isolation of Stachybotrys from the lung of
a child with pulmonary hemosiderosis.  Pediatrics.1999;104:964-966.
Joffe AZ. Fusarium Species, Their Biology and Toxicology. New York, NY: Wiley; 1986.
Bondy GS, Pestka JJ. Immunomodulation by fungal toxins.  J Toxicol Environ Health B Crit Rev.2000;3:109-143.
Easterling DR, Meehl GA, Parmesan C.
 et al.  Climate extremes: observations, modeling, and impacts.  Science.2000;289:2068-2074.
Greenough G, McGeehin M, Bernard SM.
 et al.  The potential impacts of climate variability and change on health impacts
of extreme weather events in the United States.  Environ Health Perspect.2001;109(suppl 2):191-198.
Not Available.  Guidance for Industry on Fumonisin Levels in Human Foods and
Animal Feeds. Â Rockville, Md: US Food and Drug Administration; 2000.
Creasia DA, Lambert RJ. Acute respiratory tract toxicity of the trichothecene mycotoxin, T-2
toxin. In: Beasley VR, ed. Trichothecene Mycotoxicosis:
Pathophysiologic Effects. Boca Raton, Fla: CRC Press; 1989:161-170.